The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - MedImmune; Novartis
Phase 1/2 study of durvalumab and tremelimumab as monotherapy and in combination in patients with unresectable hepatocellular carcinoma (HCC).
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Aduro Biotech (I); Astellas Pharma; AstraZeneca (I); Celgene; Celsion; cipla; Exelixis; IntegraGen; Jennerex; Lilly/ImClone; MedImmune; Novartis; Pharmacyclics (I); Sanofi (I); Silenseed (I); Vicus Therapeutics
Research Funding - Abbott Laboratories (Inst); Amgen (Inst); Bayer (Inst); Exelixis (Inst); Genentech (Inst); Lilly/ImClone (Inst); Novartis (Inst); Polaris (Inst); Roche (Inst); Vicus Therapeutics (Inst)
Travel, Accommodations, Expenses - Polaris
 
Bruno Sangro
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; MedImmune
Speakers' Bureau - Bayer; Bristol-Myers Squibb; MedImmune
 
Michael Morse
Stock and Other Ownership Interests - PhytoChem
Honoraria - Astellas Pharma; Bayer; Boehringer Ingelheim; EMD Serono; Etubics; Genentech/Roche; Ipsen; Lexicon; Merrimack; Novartis; Onyx; Regeneron; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech/Roche; Novartis
Research Funding - Advanced Accelerator Applications (Inst); AlphaVax (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lexicon (Inst); MedImmune (Inst); Onyx (Inst); Precision Biologics (Inst)
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Sanofi
Research Funding - Bayer; Novartis
 
Ann-Lii Cheng
No Relationships to Disclose
 
Masatoshi Kudo
Honoraria - Ajinomoto; Bayer; Eisai; Kaken Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Chugai Pharma; Kowa; Taiho Pharmaceutical
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Kowa (Inst); Lilly (Inst); Novartis (Inst); Pfizer; Taiho Pharmaceutical (Inst)
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech
 
Stephen L. Chan
No Relationships to Disclose
 
Joyce Antal
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline
 
Jillian Boice
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Feng Xiao
Employment - GlaxoSmithKline; MedImmune; Salix
Stock and Other Ownership Interests - GlaxoSmithKline; Salix
 
Shannon R. Morris
Employment - GlaxoSmithKline; MedImmune
Stock and Other Ownership Interests - GlaxoSmithKline; MedImmune
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Johanna Bendell
No Relationships to Disclose